Suicide is one of the leading causes of death in the world, and the United States has one of the highest suicide rates among the...

Psychedelic users have long reported experiencing profound shifts in how they perceive consciousness following a psychedelic experience....

As clinical trials and research into the use of psychedelics as therapeutic interventions for complex mental health conditions like...

A Canadian biotech company recently announced the results of their Phase 2 study that explored the viability of using ketamine as a...

Eating Disorders (ED) and Post-Traumatic Stress Disorder (PTSD) are strongly correlated, however, no proven treatment options are...

The world's largest annual drug survey, The Global Drug Survey (GDS) recently published the results of their 2021 survey which found that...

John Hopkins University researchers have published the results of a follow-up study of patients with major depressive disorder (MDD) who...

A group of researchers recently analyzed reports of psychedelic experiences from five different substances to better understand the...

The viability of psychedelic compounds as a treatment option for a variety of mental health disorders has been gaining steady momentum...

A recent phase II double-blind placebo-controlled study conducted by Awakn Life Sciences, a Canadian biotech company focused on solutions...

Dementia is a debilitating neurodegenerative disease impacting 1 in 7 Americans over the age of 70 with many more struggling with...

A recent phase 1, randomized, double-blind, placebo-controlled study conducted by the Institute of Psychiatry, Psychology, & Neuroscience...